6 results
diagnosis rheumatology druginduced summary treatment activation cardiology comparison constrictive cp echocardiogram erythematosus hematology hemophagocytic hlh macrophage mas pericarditis s4c septalbounce
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
Lupus (DIL): ... to 1:1 F:M • Clinical ... , SCLE-DIL (terbinafine ... Discontinuation of causal ... of SLE • Evolution
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
and Management ... 40, F:M 9:1 • Clinical ... versus DIL • ... Positive in 60-80% of cases ... of SLE • Evolution
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Hemophagocytic Lymphohistiocytosis ... accumulation of clinical ... Autoimmune diseases: SLE ... inhibitors under evaluation ... #diagnosis #management
Constrictive Pericarditis on POCUS Echocardiogram - Subcostal View Young Lupus patient admitted to hospital new onset HFpEF.
Pericarditis on POCUS ... What do you see ... could pinpoint the cause ... Did have tap next ... Echocardiogram #clinical
►
 Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... , SCLE-DIL (terbinafine ... Discontinuation of causal ... • Evolution: ... diagnosis #treatment #management
Macrophage Activation Syndrome (MAS) Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH) What? A subset of
haemophagocytic lymphohistiocytosis ... disease • Systemic lupus ... SJIA], systemic lupus ... erythematosus [SLE ... Syndrome #Diagnosis #Management
No results found for "ddxof evaluation aorta causes clinical lupus management sle pocus dil lymphohistiocytosis"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ddxof #evaluation #aorta #causes #clinical #lupus #management #sle #pocus #dil #lymphohistiocytosis